Trial intelligence / Profile preview

Vaginal Lactoferrin for Amniotic Fluid Cytokines

NCT02843984Completed

Sponsor
University of Ferrara
Start
Mar 2011
Primary completion
Mar 2012
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, open-label trial of lactoferrin in pregnancy complications (3 arms), sponsored by University of Ferrara. Primary endpoint: Amniotic fluid concentration of mediators involved in inflammation. Started Mar 2011; status: completed.

02

Drugs

lactoferrin
03

Conditions

pregnancy complications

Beyond the preview

Go deeper on NCT02843984.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02843984.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call